Physician profile

Jeffrey R Desantis

Foot & Ankle Surgery · Orange, CA

NPI 1659371748

$8,676.79

in general payments reported to CMS, 2019-2025

21 companies · none reported in 2025

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Honoraria$2,240.00
Travel and Lodging$1,409.10
Gift$1,039.33
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$980.00
Food and Beverage$380.76

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Averitas Pharma INC. $4,434.28 2023-2024 Qutenza
Heron Therapeutics, INC. $1,535.16 2021
Iq Med LLC $1,412.17 2022-2023
Treace Medical Concepts, INC. $514.62 2023
Horizon Therapeutics Plc $141.36 2019-2020
Zimmer Biomet Holdings, INC. $131.36 2019-2020
Stryker Corporation $108.16 2020-2021
Novastep INC. $78.94 2022
Ortho Dermatologics, A Division of Bausch Health US, LLC $65.22 2022
Smith+Nephew, INC. $36.99 2020-2022
Kerecis Limited $36.51 2021
Collaborative Care Diagnostics, LLC $33.80 2024
Integra Lifesciences Corporation $29.52 2020
Saxum Surgical, INC. $27.16 2023
Bard Peripheral Vascular, INC. $22.71 2021
Show all 20 companies
CompanyGeneral paymentsYearsTop products
Medartis INC. $19.24 2020
Tactile Systems Technology INC $16.19 2021
Acell, INC. $15.10 2020
Amniox Medical, INC. $13.28 2020
Grt US Holding, INC. $5.02 2022

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$591,520.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeffrey R Desantis

$8,676.79

in general payments reported 2019-2025

Years
2019-2025
Top company
Averitas Pharma INC.

https://glasscript.com/doctor/29966/jeffrey-r-desantis

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.